Literature DB >> 17581213

Can nitric oxide-generating compounds improve the oxidative stress response in experimentally diabetic rats?

Ahmed M A Mohamadin1, Lamiaa N A Hammad, Mohamed Fath El-Bab, Hala S Abdel Gawad.   

Abstract

1. The present study was designed to evaluate the protective effects of the nitric oxide (NO)-generating compounds L-arginine (L-Arg) and sodium nitroprusside (SNP) on oxidative stress markers in streptozotocin (STZ)-diabetic rats. 2. Diabetes was induced after a single intraperitoneal injection of STZ (60 mg/kg). Rats were divided into non-diabetic (control), diabetic and treated diabetic groups. The treated diabetic groups were supplemented with L-Arg (300 mg/kg), SNP (3 mg/kg per day) or glibenclamide (0.6 mg/kg per day) orally for 4 weeks. 3. At the end of the experiment, fasted rats were killed by cervical decapitation. Blood was collected for estimation of glucose, haemoglobin, glycosylated haemoglobin (HbA(1c)), total cholesterol, high-density lipoprotein-cholesterol and triglycerides. Thiobarbituric acid-reactive substances (TBARS; an index of lipid peroxidation), superoxide dismutase, glutathione peroxidase, catalase, nitrate/nitrite (NO(x)) and reduced glutathione (GSH) were estimated in liver and kidney homogenates. 4. A significant increase was observed in plasma glucose levels and HbA(1c), with a concomitant decrease in haemoglobin levels, in diabetic rats. These alterations reverted back to near normal after treatment with the NO-generating compounds. A loss of bodyweight, polydipsia, polyphagia and elevated levels of serum cholesterol and triglycerides were observed in diabetic rats. Hyperglycaemia was accompanied by a significant increase in tissue TBARS and a decrease in NO(x), GSH and anti-oxidant enzymes, whereas, supplementation with L-Arg and SNP significantly reduced TBARS levels and increased GSH and anti-oxidant enzyme activities. Linear regression analysis indicated that blood glucose and TBARS had a significant positive correlation with HbA(1c), whereas a negative correlation was observed between GSH and NO(x). 5. It is concluded that NO-generating compounds improve most of the biochemical abnormalities and anti-oxidant levels in diabetic rats. The beneficial effects of NO-generating compounds can be attributed to the generation of NO and/or enhanced anti-oxidant enzyme activities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581213     DOI: 10.1111/j.1440-1681.2007.04622.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

1.  Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats.

Authors:  Mustafa Cemek; Sadik Kağa; Nejdet Simşek; Mehmet Emin Büyükokuroğlu; Muhsin Konuk
Journal:  J Nat Med       Date:  2008-02-13       Impact factor: 2.343

2.  Renal response to L-arginine in diabetic rats. A possible link between nitric oxide system and aquaporin-2.

Authors:  María C Ortiz; María F Albertoni Borghese; Sabrina E Balonga; Agustina Lavagna; Ana L Filipuzzi; Rosana Elesgaray; María A Costa; Mónica P Majowicz
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

3.  L-arginine supplementation and risk factors of cardiovascular diseases in healthy men: a double-blind randomized clinical trial.

Authors:  Naseh Pahlavani; Mostafa Jafari; Omid Sadeghi; Masoud Rezaei; Hamid Rasad; Hossein Ali Rahdar; Mohammad Hasan Entezari
Journal:  F1000Res       Date:  2014-12-12

4.  Antioxidant, antidiabetic and hypolipidemic effects of Tulbaghia violacea Harv. (wild garlic) rhizome methanolic extract in a diabetic rat model.

Authors:  Kogi Moodley; Kimane Joseph; Yougasphree Naidoo; Shahidul Islam; Irene Mackraj
Journal:  BMC Complement Altern Med       Date:  2015-11-17       Impact factor: 3.659

5.  The Protective Effect of L-arginine in Cisplatin-induced Nephrotoxicity in Streptozotocin-induced Diabetic Rats.

Authors:  Fatemeh Gharibi; Nepton Soltani; Maryam Maleki; Ardeshir Talebi; Masoumeh Nasiri; Soheyla Shirdavani; Mehdi Nematbakhsh
Journal:  Adv Biomed Res       Date:  2017-08-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.